Literature DB >> 3844051

Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice.

D M Ornitz, R D Palmiter, R E Hammer, R L Brinster, G H Swift, R J MacDonald.   

Abstract

Transfection of genes into tissue culture cell lines has demonstrated that relatively short DNA sequences can allow expression of immunoglobulin, insulin and chymotrypsin genes in their appropriate cell types. A definitive test of cell-specific gene expression, however, requires testing genes in every possible cell type, an experiment performed easily by introducing the gene in question into the germ line of an animal. Transfer of intact genes into mice has demonstrated that a mouse immunoglobulin kappa gene is expressed specifically in B lymphocytes, a rat elastase I gene is expressed specifically in pancreas and a chicken transferrin gene is expressed preferentially in liver. Mouse metallothionein-growth hormone fusion genes introduced into mice are preferentially expressed in the liver, consistent with the expression of endogenous metallothionein genes, but initial experiments with beta-globin genes have not revealed proper regulation. To identify the DNA elements required for pancreas-specific expression of the rat elastase I gene, we joined the 5'-flanking region of this gene to the human growth hormone (hGH) structural gene and introduced the fusion gene into mice. Here we demonstrate that a fusion gene containing only 213 base pairs (bp) of elastase I gene sequence directs expression of hGH in pancreatic acinar cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3844051     DOI: 10.1038/313600a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  73 in total

1.  Primary culture of avian pancreatic acinar cells for heterologous gene expression.

Authors:  J Hall; I R Jowsey; B Brown
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

Review 2.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  RNA profiling and chromatin immunoprecipitation-sequencing reveal that PTF1a stabilizes pancreas progenitor identity via the control of MNX1/HLXB9 and a network of other transcription factors.

Authors:  Nancy Thompson; Emilie Gésina; Peter Scheinert; Philipp Bucher; Anne Grapin-Botton
Journal:  Mol Cell Biol       Date:  2012-01-09       Impact factor: 4.272

4.  Exocrine pancreas transcription factor 1 binds to a bipartite enhancer element and activates transcription of acinar genes.

Authors:  S L Weinrich; A Meister; W J Rutter
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

5.  Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene.

Authors:  Y Li; R F Shen; S Y Tsai; S L Woo
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).

Authors:  G H Swift; Y Liu; S D Rose; L J Bischof; S Steelman; A M Buchberg; C V Wright; R J MacDonald
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 8.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

9.  Chromogranin B (secretogranin I), a neuroendocrine-regulated secretory protein, is sorted to exocrine secretory granules in transgenic mice.

Authors:  S Natori; A King; A Hellwig; U Weiss; H Iguchi; B Tsuchiya; T Kameya; R Takayanagi; H Nawata; W B Huttner
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.

Authors:  Jean-Paul De La O; L Charles Murtaugh
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.